Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Recruiting · NCT05996159 · Interventional (participants receive a specific treatment) · Lead sponsor: Seoul National University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
AI-guided ablation only for PVIQDOT MicroTM catheter
What this trial is about
This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients undergoing PVI for PAF
Exclusion criteria
- Aged less than 19 years
- Patients with persistent AF
- Patients with previous ablation or surgery for AF
- Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
- Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
- Patients with contraindication(s) for using oral anticoagulants
- Patients with LA anteroposterior diameter of more than 55 mm
- Patients with left ventricular ejection fraction less than 35%
- Pregnants or those who plan to become pregnant during the study
- Life expectancy less than a year
Where it is running
1 location listed.
- Seoul National University Hospital - Seoul, South Korea